Nephrocare Health Services has scheduled its earnings conference call for Wednesday, August 12, 2026, at 10:00 AM IST to discuss its financial performance for the first quarter of fiscal year 2027 (Q1FY27). The event serves as a platform for investors and analysts to engage with the company's leadership regarding the unaudited standalone and consolidated financial results for the quarter ended June 30, 2026. This disclosure ensures transparency and provides stakeholders with direct access to management’s perspective on recent operational outcomes and strategic direction.

The announcement was made pursuant to Regulation 30 read with Schedule III of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. Nephrocare Health Services Limited, formerly known as Nephrocare Health Services Private Limited, filed the intimation with both the Bombay Stock Exchange (BSE) and the National Stock Exchange of India Limited (NSE). The company emphasized that discussions during the call will be based solely on publicly available information, with no intention to disclose unpublished price-sensitive information (UPSI).

Key Management Participants

The conference call will feature senior executives from NephroPlus, the brand under which the company operates as Asia's Largest Dialysis Network. The following officials are confirmed to participate in the discussion:

These leaders will address queries related to the company’s business strategy and future outlook post the declaration of its Q1FY27 financial results.

Call Logistics and Access Details

Investors can join the call via dial-in numbers provided for domestic and international participants. The event is organized in collaboration with IIFL, which has provided pre-registration links and contact details for further assistance. Below are the access details for the conference call:

For additional information, investors may contact Naman Bagrecha, Rahul Jeewani, Aman Goyal, or Vighnesh Indure at IIFL Capital Markets using the provided telephone numbers and email addresses. The full disclosure document is also available on the company’s official website at www.nephroplus.com .

Nephrocare Health Services Limited has scheduled its 17th Annual General Meeting (AGM) for Wednesday, August 12, 2026, at 2:30 P.M. IST through Video Conferencing (VC) and Other Audio Visual Means (OAVM). The meeting will be conducted entirely through virtual mode in compliance with the Companies Act, 2013, and relevant SEBI regulations. The company has fixed Wednesday, August 5, 2026, as the cut-off date to determine the eligibility of members to participate in the AGM and avail of remote e-voting facilities. The Register of Members and Share Transfer Books will remain closed from August 6, 2026, to August 12, 2026.

The agenda for the meeting includes the adoption of audited financial statements for the financial year ended March 31, 2026, and the re-appointment of Mr. Gaurav Sharma as a Nominee Director. Shareholders will also vote on special resolutions to approve the 'NephroPlus Employee Stock Option Scheme – 2026' and to extend its benefits to employees of subsidiary and associate companies. The scheme proposes the grant of up to 20,06,814 options, exercisable into equity shares of ₹ 2 each.

Additionally, the meeting seeks approval for clarificatory amendments to the remuneration framework of Mr. Vikram Vuppala, Chairman & Managing Director. The amendments aim to expressly define the performance-linked variable remuneration component based on 'Audited Adjusted Consolidated Operating EBITDA' without altering the overall remuneration structure or limits. Another special business item involves the approval of the Promote Incentive Arrangement between the Founder Promoter and certain shareholders, which does not involve any financial obligation for the company.

Remote e-Voting Schedule

Members entitled to vote may cast their ballots electronically through the remote e-voting facility provided by National Securities Depository Limited (NSDL). The remote e-voting period commences prior to the meeting and concludes the day before the AGM.

Members who have already cast their votes via remote e-voting may attend the AGM but will not be entitled to vote again during the meeting. The remote e-voting mode will be disabled by NSDL after the specified end time.

Participation and Technical Support

Shareholders can attend the AGM by logging into the NSDL e-voting system. Detailed procedures for accessing the meeting and casting votes are outlined in the AGM Notice. Members who have acquired shares after the dispatch of the notice but hold them as on the cut-off date are advised to contact the company for the necessary login credentials.

For technical assistance regarding login or e-voting, shareholders holding securities in demat mode with NSDL may contact evoting@nsdl.com or call 022-4886 7000. Those holding shares with CDSL may reach out to helpdesk.evoting@cdslindia.com or call the toll-free number 1800-21-09911.

Source: https://lodr-files.dhan.co/lodr-inputs/Company/INE428V01029/4470afcc4be04eb5.pdf